Uremic solutes from colon microbes

Kidney International

Volumn 81, Issue 10, 2012, Pages 949-954

  Meyer, Timothy W ^a   Hostetter, Thomas H ^b  

^a STANFORD UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hemodialysis; Nutrition; Uremic toxins

Indexed keywords

INDICAN; LACTULOSE; PARA CRESOL; RIFAXIMIN;

BIOACCUMULATION; BIOSYNTHESIS; COLON FLORA; CORRELATIONAL STUDY; DISEASE ASSOCIATION; HEMODIALYSIS; HEPATIC ENCEPHALOPATHY; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER FUNCTION; MASS SPECTROMETRY; METABOLOMICS; MICROBIAL METABOLISM; ORGANIC WASTE; PRIORITY JOURNAL; REVIEW; SOLUTE; TOXICITY; UREMIC ORGANIC WASTE;

EID: 84860367327     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.504     Document Type: Short Survey

References (47)

1. Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007; 449: 811-818.
2. Goodman AL, Gordon JI. Our unindicted coconspirators: human metabolism from a microbial perspective. Cell Metab 2010; 12: 111-116.
3. Walter J, Britton RA, Roos S. Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proc Natl Acad Sci USA 2011; 108(Suppl 1): 4645-4652.
4. Nordgaard I, Mortensen PB. Digestive processes in the human colon. Nutrition 1995; 11: 37-45.
5. Wikoff WR, Anfora AT, Liu J et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 2009; 106: 3698-3703.
6. Evenepoel P, Meijers BK, Bammens BR et al. Uremic toxins originating from colonic microbial metabolism. Kidney Int Suppl 2009; 76(Suppl 114): S12-S19.
7. Schepers E, Glorieux G, Vanholder R. The gut: the forgotten organ in uremia? Blood Purif 2010; 29: 130-136.
8. Kolff WJ. The Artificial Kidney. J. H. Kok: Kampen, 1946.
9. Chen TS, Chen PS. Intestinal autointoxication: a medical leitmotif. J Clin Gastroenterol 1989; 11: 434-441.
10. Ludwig GD, Senesky D, Bluemle Jr LW et al. Indoles in ureamia: identification by countercurrent distribution and paper chromatography. Am J Clin Nutr 1968; 21: 436-450.
11. Niwa T. Indoxyl sulfate is a nephro-vascular toxin. J Ren Nutr 2010; 20: S2-S6.
12. Vanholder R, Bammens B, de Loor H et al. Warning: the unfortunate end of p-cresol as a uraemic toxin. Nephrol Dial Transplant 2011; 26: 1464-1467.
13. Niwa T, Maeda K, Ohki T et al. A gas chromatographic-mass spectrometric analysis for phenols in uremic serum. Clin Chim Acta 1981; 110: 51-57.
14. Van Haard P, Pavel S. Chromatography of urinary indole derivatives. J Chromatogr 1988; 429: 59-94.
15. Niwa T. Recent progress in the analysis of uremic toxins by mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 2600-2606.
16. Rhee EP, Souza A, Farrell L et al. Metabolite profiling identifies markers of uremia. J Am Soc Nephrol 2010; 21: 1041-1051.
17. Kikuchi K, Itoh Y, Tateoka R et al. Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878: 1662-1668.
18. Sato E, Kohno M, Yamamoto M et al. Metabolomic analysis of human plasma from haemodialysis patients. Eur J Clin Invest 2011; 41: 241-255.
19. Wikoff WR, Nagle MA, Kouznetsova VL et al. Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1). J Proteome Res 2011; 10: 2842-2851.
20. Kikuchi K, Itoh Y, Tateoka R et al. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878: 2997-3002.
21. Aronov P, Luo FY, Plummer NS et al. Colonic contribution to uremic solutes. J Am Soc Nephrol 2011; 22: 1769-1776.
22. Roux A, Lison D, Junot C et al. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: a review. Clin Biochem 2011; 44: 119-135.
23. De Smet R, Van Kaer J, Van Vlem B et al. Toxicity of free p-cresol: a prospective and cross-sectional analysis. Clin Chem 2003; 49: 470-478.
24. Bammens B, Evenepoel P, Keuleers H et al. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006; 69: 1081-1087.
25. Faure V, Dou L, Sabatier F et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 2006; 4: 566-573.
26. Meijers BK, Van Kerckhoven S, Verbeke K et al. The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 2009; 54: 891-901.
27. Hosoya KI, Tachikawa M. Roles of organic anion/cation transporters at the blood-brain and blood-cerebrospinal fluid barriers involving uremic toxins. Clin Exp Nephrol 2011; 15: 478-485.
28. Wang Z, Klipfell E, Bennett BJ et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472: 57-63.
29. Chacko A, Cummings JH. Nitrogen losses from the human small bowel: obligatory losses and the effect of physical form of food. Gut 1988; 29: 809-815.
30. Bammens B, Verbeke K, Vanrenterghem Y et al. Evidence for impaired assimilation of protein in chronic renal failure. Kidney Int 2003; 64: 2196-2203.
31. Meijers BK, De Preter V, Verbeke K et al. p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrol Dial Transplant 2009; 25: 219-224.
32. De Preter V, Hamer HM, Windey K et al. The impact of pre-and/or probiotics on human colonic metabolism: does it affect human health? Mol Nutr Food Res 2011; 55: 46-57.
33. Kalantar-Zadeh K, Kopple JD, Deepak S et al. Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr 2002; 12: 17-31.
34. Elia M, Cummings JH. Physiological aspects of energy metabolism and gastrointestinal effects of carbohydrates. Eur J Clin Nutr 2007; 61(Suppl 1): S40-S74.
35. Stephen AM, Wiggins HS, Cummings JH. Effect of changing transit time on colonic microbial metabolism in man. Gut 1987; 28: 601-609.
36. Pham NM, Recht NS, Hostetter TH et al. Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis. Clin J Am Soc Nephrol 2008; 3: 85-90.
37. Goodman AL, Kallstrom G, Faith JJ et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci USA 2011; 108: 6252-6257.
38. Riordan SM, Williams R. Gut flora and hepatic encephalopathy in patients with cirrhosis. N Engl J Med 2010; 362: 1140-1142.
39. Meyer TW, Sirich TL, Hostetter TH. Dialysis cannot be dosed. Semin Dial 2011; 24: 471-479.
40. Meyer TW, Leeper EC, Bartlett DW et al. Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutes. J Am Soc Nephrol 2004; 15: 1927-1935.
41. Luo FJ, Patel KP, Marquez IO et al. Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of proteinbound solutes: a pilot crossover trial. Am J Kidney Dis 2009; 53: 1042-1049.
42. Meijers BK, Bammens B, Verbeke K et al. A review of albumin binding in CKD. Am J Kidney Dis 2008; 51: 839-850.
43. Meert N, Waterloos MA, Van Landschoot M et al. Prospective evaluation of the change of predialysis protein-bound uremic solute concentration with postdilution online hemodiafiltration. Artif Organs 2010; 34: 580-585.
44. Eloot S, Schepers E, Barreto DV et al. Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins. Clin J Am Soc Nephrol 2011; 6: 1266-1273.
45. Niwa T, Miyazaki T, Tsukushi S et al. Accumulation of indoxyl-beta-Dglucuronide in uremic serum: suppression of its production by oral sorbent and efficient removal by hemodialysis. Nephron 1996; 74: 72-78.
46. Lesaffer G, De Smet R, Belpaire FM et al. Urinary excretion of the uraemic toxin p-cresol in the rat: contribution of glucuronidation to its metabolization. Nephrol Dial Transplant 2003; 18: 1299-1306.
47. Dawson LF, Donahue EH, Cartman ST et al. The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains. BMC Microbiol 2011; 11: 86.